SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates EQ, MTCR, KNBE, IMRA
Nov 24th, 2022 12:17 EST
NEW YORK, Nov. 24, 2022 /PRNewswire/ -- Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws and/or breaches of fiduciary duties to shareholders relating to:
Equillium, Inc. (NASDAQ: EQ)'s merger with Metacrine Inc. If you are an Equillium shareholder, click here to learn more about your rights and options.
Metacrine Inc. (NASDAQ: MTCR)'s merger with Equillium, Inc. If you are a Metacrine shareholder, click here to learn more about your rights and options.
KnowBe4, Inc. (NASDAQ: KNBE)'s sale to Vista Equity Partners for $24.90 per share in cash. If you are a KnowBe4 shareholder, click here to learn more about your rights and options.
Imara Inc. (NASDAQ: IMRA)'s merger with Enliven Therapeutics, Inc. If you are an Imara shareholder, click here to learn more about your rights and options.
Halper Sadeh LLC may seek increased consideration for shareholders, additional disclosures and information concerning the proposed transaction, or other relief and benefits on behalf of shareholders.
Shareholders are encouraged to contact the firm free of charge to discuss their legal rights and options. Please call Daniel Sadeh or Zachary Halper at (212) 763-0060 or email [email protected] or [email protected].
Halper Sadeh LLC represents investors all over the world who have fallen victim to securities fraud and corporate misconduct. Our attorneys have been instrumental in implementing corporate reforms and recovering millions of dollars on behalf of defrauded investors.
Attorney Advertising. Prior results do not guarantee a similar outcome.
SOURCE Halper Sadeh LLP